07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Dear Sir/Madam, We would like to alert you to the new rules for entering the Russian Federation thr...
Read More >
On December 18, 2019, the National Labor Relations Board’s (Board or NLRB) published a final rule—...
Read More >
Warburg Pincus and Martis Capital are merging their respective portfolio companies, Qualifacts and C...
Read More >
JPMorgan is preparing to finalize a deal with federal prosecutors and regulators in which the bank w...
Read More >
The Illinois Workplace Transparency Act (the Act), which passed the Illinois legislature in May and ...
Read More >
In this report, we set out the key real estate developments in the US during the period of disruptio...
Read More >